A blocked nostril could be due to allergies, nasal polyps, a deviated septum, or other causes. Use saline rinses and stay hydrated to help clear a blocked nostril. If symptoms persist, see a ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...

Tezepelumab-ekko is now approved for chronic rhinosinusitis with nasal polyps (CRSwNP), targeting thymic stromal lymphopoietin and marking its second indication after severe asthma. The phase 3 ...

On October 17, 2025, the FDA approved tezepelumab (Tezspire; AstraZeneca and Amgen) as an add-on maintenance treatment for adults and adolescents aged 12 years and older with inadequately controlled ...

Los Angeles Rhinoplasty Pros announced today the launch of a comprehensive online educational resource designed to inform prospective rhinoplasty patients throughout the Los Angeles and Beverly Hills ...

The medical landscape for chronic rhinosinusitis is rapidly advancing, with new treatments offering hope for improved quality of life for patients. As pharmaceutical companies race to develop ...

– In this 24-week study, VIBRANT met its primary endpoint, with verekitug dosed every 12 weeks leading to a statistically significant and clinically meaningful reduction from baseline in ...

cSurgical Intervention Trials Unit, University of Oxford, Oxford, UK dOxford Clinical Trials Research Unit, University of Oxford, Oxford, UK ...